$1.43 EPS Expected for Walgreens Boots Alliance Inc (NASDAQ:WBA) This Quarter

Analysts predict that Walgreens Boots Alliance Inc (NASDAQ:WBA) will report earnings of $1.43 per share for the current fiscal quarter, Zacks reports. Six analysts have made estimates for Walgreens Boots Alliance’s earnings, with estimates ranging from $1.38 to $1.47. Walgreens Boots Alliance posted earnings per share of $1.48 during the same quarter last year, which indicates a negative year-over-year growth rate of 3.4%. The company is expected to issue its next quarterly earnings report on Thursday, October 10th.

According to Zacks, analysts expect that Walgreens Boots Alliance will report full year earnings of $5.99 per share for the current year, with EPS estimates ranging from $5.95 to $6.03. For the next financial year, analysts forecast that the firm will post earnings of $5.99 per share, with EPS estimates ranging from $5.81 to $6.08. Zacks’ EPS calculations are an average based on a survey of research firms that that provide coverage for Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company had revenue of $34.59 billion during the quarter, compared to the consensus estimate of $34.52 billion. During the same period in the previous year, the company posted $1.53 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up .7% on a year-over-year basis.

A number of analysts have recently commented on WBA shares. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, June 28th. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price target for the company. in a research report on Monday, June 10th. Citigroup dropped their price target on Walgreens Boots Alliance from $76.00 to $60.00 and set a “neutral” rating for the company in a research report on Wednesday, April 3rd. Morgan Stanley set a $61.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Tuesday, May 14th. Finally, JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday, June 28th. Six investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $63.82.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the sale, the chief accounting officer now directly owns 435,811 shares in the company, valued at approximately $23,119,773.55. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 15.73% of the stock is owned by corporate insiders.

Large investors have recently modified their holdings of the business. Roman Butler Fullerton & Co. lifted its stake in shares of Walgreens Boots Alliance by 28.8% in the 1st quarter. Roman Butler Fullerton & Co. now owns 22,127 shares of the pharmacy operator’s stock valued at $1,400,000 after purchasing an additional 4,942 shares during the last quarter. Newman Dignan & Sheerar Inc. lifted its stake in shares of Walgreens Boots Alliance by 22.9% in the 1st quarter. Newman Dignan & Sheerar Inc. now owns 4,616 shares of the pharmacy operator’s stock valued at $292,000 after purchasing an additional 861 shares during the last quarter. Kaizen Advisory LLC lifted its stake in shares of Walgreens Boots Alliance by 20.3% in the 4th quarter. Kaizen Advisory LLC now owns 2,316 shares of the pharmacy operator’s stock valued at $158,000 after purchasing an additional 391 shares during the last quarter. Truvestments Capital LLC acquired a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at $312,000. Finally, Trust Investment Advisors lifted its stake in shares of Walgreens Boots Alliance by 4.5% in the 1st quarter. Trust Investment Advisors now owns 9,260 shares of the pharmacy operator’s stock valued at $586,000 after purchasing an additional 400 shares during the last quarter. Institutional investors own 62.19% of the company’s stock.

NASDAQ:WBA traded down $0.42 during trading hours on Thursday, reaching $54.07. The company had a trading volume of 4,886,735 shares, compared to its average volume of 6,058,927. The company has a market capitalization of $49.21 billion, a price-to-earnings ratio of 8.98, a PEG ratio of 1.38 and a beta of 0.82. Walgreens Boots Alliance has a 1-year low of $49.31 and a 1-year high of $86.31. The stock has a 50 day moving average price of $54.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.37 and a current ratio of 0.76.

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th will be issued a $0.458 dividend. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 annualized dividend and a yield of 3.39%. The ex-dividend date of this dividend is Monday, August 19th. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Cash Flow Analysis in Stock Selection

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.